相关实验视频

Updated: Jun 17, 2025

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

空气污染氨基代被光玛分泌酶调节器GSM-15606减弱

Jose A Godoy-Lugo¹, Max A Thorwald¹, Mafalda Cacciottolo^1,2

¹Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|August 12, 2024

概括

长期暴露于空气污染会增加阿尔茨海默病的风险,因为它会增加粉样蛋白β (Aβ) 42. 一种玛分泌酶调节器,GSM-15606,在暴露于空气污染的小鼠中降低了Aβ42,这表明了潜在的治疗益处.

科学领域:

环境健康环境健康
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

慢性空气污染 (AirPoll) 与认知能力下降和阿尔茨海默病 (AD) 风险增加有关.
在动物中,AirPoll暴露会增加粉样蛋白的含量,并导致行为缺陷.

研究的目的:

调查玛分泌酶调节器GSM-15606对空气污染诱导的粉样蛋白β (Aβ) 42产生的保护作用.
评估GSM-15606在暴露于各种空气污染成分期间对Aβ42水平的影响.

主要方法:

野生类型的小鼠被口服GSM-15606.
小鼠接受了为期8周的空气污染分片的吸入暴露,包括纳米颗粒物 (nPM) 和柴油废气颗粒 (DEP).
测量了粉样蛋白β (Aβ) 42水平,分泌酶活性和蛋白质水平.

主要成果:

在暴露于nPM和DEP期间,GSM-15606显著降低了Aβ42水平.
没有观察到β或分泌酶活性或BACE1和PS1蛋白水平的显著变化.
柴油废气颗粒暴露导致侧腔室体积增加25%.

结论:

通过GSM-15606对Aβ42的减弱,可以防止空气污染对认知健康的有害影响.
这些发现与开发AD药物治疗和理解Aβ42生理学有关.
对于GSM-15606对Aβ稳态的影响,在针对粉样蛋白减少的AD治疗策略中需要考虑.

关键词:

根据AirPoll的调查结果,在GSM-15606中使用.空气污染空气污染粉样蛋白衰减化剂柴油废气颗粒的使用情况玛分泌酶调节器是什么纳米颗粒物是一种纳米颗粒物.

更多相关视频

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...